Literature DB >> 24893800

Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib.

Mirela Andrei1, Hemant Sindhu, Jen Chin Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24893800     DOI： 10.3109/10428194.2014.924121

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Authors:  A Tefferi; H K Al-Ali; G Barosi; T Devos; H Gisslinger; Q Jiang; J-J Kiladjian; R Mesa; F Passamonti; M F McMullin; V Ribrag; G Schiller; A M Vannucchi; D Zhou; D Reiser; J Zhong; R P Gale
Journal:  Leukemia       Date:  2016-10-24       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.